Seeking AlphaCodex · 实盘不做把握 3/10
北京时间·🕒 发布 02:21:14时区推断·⟳ 抓取 02:21:22·⚡ 决策 08-06 02:33:35 +12m13s·82.9 天前
Rapport Therapeutics披露二季度亏损扩大但现金可支撑至2029年下半年
二季度净亏损从上年同期2660万美元扩大至5660万美元，但公司同时给出现金 runway 至2029年下半年的流动性缓冲。
📄 原文Seeking Alpha↗ 原文
Rapport Therapeutics reports Q2 results
Earnings News Rapport Therapeutics reports Q2 results Aug 05, 2026, 2:21 PM ET Rapport Therapeutics, Inc. (RAPP) Stock…
不做 Rapport Therapeutics（RAPP.US）
常规财报快讯仅披露亏损扩大与现金 runway，未包含临床、监管、融资或商业化 surprise；方向混合且无短线正期望，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-05 · 扩散 low · price-in 风险 medium ↗
关键理由
- 二季度净亏损从上年同期2660万美元扩大至5660万美元，但公司同时给出现金 runway 至2029年下半年的流动性缓冲。
- 这是一条常规临床期 biotech 财报快讯，未披露临床数据、监管节点、融资条款或管线商业化进展，缺少短线重定价核心变量。
主要风险
- 亏损扩大本身对临床期公司通常已在研发投入预期内，若无管线或融资 surprise，难形成可交易 edge。
原文全文
展开原文 · 770 字
Earnings News
Rapport Therapeutics reports Q2 results
Aug 05, 2026, 2:21 PM ET
Rapport Therapeutics, Inc. (RAPP) Stock
By
:
Khushi Singh
,
SA News Editor
Rapport Therapeutics
press release
(
RAPP
): Q2 net Loss was $56.6M, as compared to $26.7M for the prior year period.
RAPP expects that cash, cash equivalents, and short-term investments as of June 30, 2026, will enable it to fund its operating expenses and capital expenditure requirements into the second half of 2029.
More on Rapport Therapeutics
Rapport Therapeutics, Inc. (RAPP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha’s Quant Rating on Rapport Therapeutics
Historical earnings data for Rapport Therapeutics
Financial information for Rapport Therapeutics
Rapport Therapeutics reports Q2 results
Aug 05, 2026, 2:21 PM ET
Rapport Therapeutics, Inc. (RAPP) Stock
By
:
Khushi Singh
,
SA News Editor
Rapport Therapeutics
press release
(
RAPP
): Q2 net Loss was $56.6M, as compared to $26.7M for the prior year period.
RAPP expects that cash, cash equivalents, and short-term investments as of June 30, 2026, will enable it to fund its operating expenses and capital expenditure requirements into the second half of 2029.
More on Rapport Therapeutics
Rapport Therapeutics, Inc. (RAPP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha’s Quant Rating on Rapport Therapeutics
Historical earnings data for Rapport Therapeutics
Financial information for Rapport Therapeutics
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。